The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer's disease in rodents.

Sci Rep · 2019 · PMC6888874 · PMID 31792284

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

failed to reach statistical significanceP = 0.10so close (0.05 < p ≤ 0.1)

SAR502250 (30 mg/kg) enhanced PPI at the intensity of 85 dB, but the effect failed to reach statistical significance (P = 0.10).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.